Skip Nav Destination
Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT
Free
Adoptive transfer of donor B lymphocytes: a phase 1/2a study for patients after allogeneic stem cell transplantation
Free
Microclots, as defined by amyloid-fibrinogen aggregates, predict risks of disseminated intravascular coagulation and mortality
Free
Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trials
Free
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia
Free
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy
Free
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia
Free
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
Free
Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission
Free
Issue Archive
May 28 2024
In this Issue
Table of Contents
INSIDE BLOOD ADVANCES
REVIEW ARTICLE
SYSTEMATIC REVIEW
CLINICAL TRIALS AND OBSERVATIONS
Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT
Free
Clinical Trials & Observations
Jaime Sanz,Myriam Labopin,Didier Blaise,Anna Maria Raiola,Alessandro Busca,Jan Vydra,Johanna Tischer,Patrice Chevallier,Stefania Bramanti,Renato Fanin,Gérard Socié,Edouard Forcade,Nicolaus Kröger,Yener Koc,Maija Itäla-Remes,Marco Zecca,Arnon Nagler,Eolia Brissot,Alexandros Spyridonidis,Ali Bazarbachi,Sebastian Giebel,Simona Piemontese,Mohamad Mohty,Fabio Ciceri
Adoptive transfer of donor B lymphocytes: a phase 1/2a study for patients after allogeneic stem cell transplantation
Free
Clinical Trials & Observations
Julia Winkler,Hannes Tittlbach,Andrea Schneider,Ingrid Vasova,Julian Strobel,Susanne Herold,Stefanie Maas,Bernd M. Spriewald,Roland Repp,Lambros Kordelas,Michael Mach,Daniel Wolff,Matthias Edinger,Andreas Mackensen,Thomas H. Winkler
Microclots, as defined by amyloid-fibrinogen aggregates, predict risks of disseminated intravascular coagulation and mortality
Free
Clinical Trials & Observations
Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trials
Free
Clinical Trials & Observations
Pau Montesinos,Amir T. Fathi,Stéphane de Botton,Eytan M. Stein,Amer M. Zeidan,Yue Zhu,Thomas Prebet,Carlos E. Vigil,Iryna Bluemmert,Xin Yu,Courtney D. DiNardo
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia
Free
Clinical Trials & Observations
Mark Levis,Alexander Perl,Gary Schiller,Amir T. Fathi,Gail Roboz,Eunice S. Wang,Jessica Altman,Trivikram Rajkhowa,Makoto Ando,Takeaki Suzuki,Ruth Ann Subach,Gary Maier,Timothy Madden,Mary Johansen,Kin Cheung,Michael Kurman,Catherine Smith
HEALTH SERVICES AND OUTCOMES
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy
Free
Clinical Trials & Observations
Reem Karmali,Rushad Machhi,Narendranath Epperla,Geoffrey Shouse,Jason Romancik,Tamara K. Moyo,Vaishalee Kenkre,Thomas A. Ollila,Lindsey Fitzgerald,Brian Hess,Kevin David,Ishan Roy,Joanna Zurko,Sayan Mullick Chowdhury,Kaitlin Annunzio,Robert Ferdman,Rahul S. Bhansali,Elyse I. Harris,Jieqi Liu,Imran Nizamuddin,Shuo Ma,Jonathan Moreira,Jane Winter,Barbara Pro,Deborah M. Stephens,Alexey Danilov,Nirav N. Shah,Jonathon B. Cohen,Stefan K. Barta,Pallawi Torka,Leo I. Gordon
IMMUNOBIOLOGY AND IMMUNOTHERAPY
LYMPHOID NEOPLASIA
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia
Free
Clinical Trials & Observations
Paul J. Hampel,Mahesh Swaminathan,Kerry A. Rogers,Erin M. Parry,Jan A. Burger,Matthew S. Davids,Wei Ding,Alessandra Ferrajoli,Jonathan M. Hyak,Nitin Jain,Saad S. Kenderian,Yucai Wang,William G. Wierda,Jennifer A. Woyach,Sameer A. Parikh,Philip A. Thompson
Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma Free
Lucienne Bogun,Annemarie Koch,Bo Scherer,Roland Fenk,Uwe Maus,Felix Bormann,Karl Köhrer,Patrick Petzsch,Thorsten Wachtmeister,Romans Zukovs,Sascha Dietrich,Rainer Haas,Thomas Schroeder,Paul Jäger,Stefanie Geyh
MYELOID NEOPLASIA
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes Free
Maria Agustina Perusini,Daniela Žáčková,Taehyung Kim,Katia Pagnano,Carolina Pavlovsky,Ivana Ježíšková,Anežka Kvetková,Tomáš Jurček,Jaeyoon Kim,Youngseok Yoo,Seongyoon Yi,Hyewon Lee,Kyoung Ha Kim,Myunghee Chang,Jose-Mario Capo-Chichi,Jessie J. F. Medeiros,Andrea Arruda,Mark Minden,Zhaolei Zhang,Sagi Abelson,Jiri Mayer,Dennis Dong Hwan Kim
PLATELETS AND THROMBOPOIESIS
Platelet proteomic profiling in sitosterolemia suggests thrombocytopenia is driven by lipid disorder and not platelet aberrations Free
Jessica Del Castillo,Anton T. J. Tool,Karin van Leeuwen,Floris P. J. van Alphen,Marion M. Brands,Monique H. Suijker,Alexander B. Meijer,Arie J. Hoogendijk,Taco W. Kuijpers
RED CELLS, IRON, AND ERYTHROPOIESIS
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency Free
Eduard J. van Beers,Hanny Al-Samkari,Rachael F. Grace,Wilma Barcellini,Andreas Glenthøj,Melissa DiBacco,Megan Wind-Rotolo,Rengyi Xu,Vanessa Beynon,Parija Patel,John B. Porter,Kevin H. M. Kuo
Amino acid supplementation confers protection to red blood cells before Plasmodium falciparum bystander stress Free
Heather Colvin Binns,Elmira Alipour,Cameron E. Sherlock,Dinah S. Nahid,John F. Whitesides,Anderson O’Brien Cox,Cristina M. Furdui,Glen S. Marrs,Daniel B. Kim-Shapiro,Regina Joice Cordy
THROMBOSIS AND HEMOSTASIS
RESEARCH LETTERS
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy Free
Megan Melody,Narendranath Epperla,Geoffrey Shouse,Jason Romancik,Pamela Allen,Tamara K. Moyo,Vaishalee Kenkre,Thomas Ollila,Lindsey Fitzgerald,Brian Hess,Kevin David,Megan M. Herr,Oluwatobi Odetola,Adam Lin,Jonathan Moreira,Shuo Ma,Jane N. Winter,Ishan Roy,Deborah Stephens,Alexey Danilov,Nirav N. Shah,Stefan K. Barta,Matthew Cortese,Jonathon B. Cohen,Leo I. Gordon,Reem Karmali
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
Free
Clinical Trials & Observations
Pier Luigi Zinzani,Gilles Salles,Alison J. Moskowitz,Armando Santoro,Amitkumar Mehta,Paul M. Barr,Neha Mehta-Shah,Graham P. Collins,Stephen M. Ansell,Joshua D. Brody,Eva Domingo-Domenech,Nathalie A. Johnson,David Cunningham,Silvia Ferrari,Julie Lisano,Jennifer Krajewski,Rachael Wen,Alev Akyol,Russell Crowe,Kerry J. Savage
Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission
Free
Clinical Trials & Observations
Irene Urbino,Etienne Lengliné,Florence Rabian,Marco Cerrano,Rathana Kim,Florian Chevillon,Dario Ferrero,Marie Sébert,Nathalie Dhédin,Raphaël Itzykson,Lionel Adès,Emmanuel Raffoux,Hervé Dombret,Ernesta Audisio,Emmanuelle Clappier,Nicolas Boissel
RESPONSE
ERRATUM
-
Cover Image
Cover Image
May-Grünwald-Giemsa–stained and partially differentiated K562 leukemia cells treated with 12-O-tetradecanoylphorbol-13-acetate. See the article by Jayne et al.
Advertisement intended for health care professionals
Advertisement intended for health care professionals